(no text — see the shared post below)
Recently published meta-analysis (May 2024) combining all 4 large long-running randomized controlled trials that tested a traditional Mediterranean diet verses heart disease.
Large long-running RCT’s are the highest quality evidence in medicine. They are at the very top of the evidence hierarchy because they directly prove causality.
- ↪ Check where a study sits on the evidence hierarchy before citing it
Summary of results for the Mediterranean diet:
(verses control diets similar to American Heart Association recommendations at the time)
- MACE events reduced by 48%
- Heart attacks reduced by 38%
- Cardiovascular mortality reduced by 46%
The 4 RCT’s included in the meta-analysis were: the Lyon Diet Heart Study, the Indo-Mediterranean Diet Heart Study, the PREDIMED Study, and the recent CORDIOPREV Study.
You can read more about the results from the individual randomized controlled trials below:
Lyon Heart Study:
- ↪ Lyon Diet Heart Study: Mediterranean diet cut cardiac death and MI 73% after a first MI
- facebook.com/share/v/19x34EAPEY
PREDIMED:
- ↪ PREDIMED NEJM: Mediterranean diet with EVOO or nuts prevents cardiovascular disease
- ↪ PREDIMED: nuts regressed carotid plaque and a nut-rich Mediterranean diet cut stroke 50%
- ↪ Nut eating >3 times a week tied to 39% lower all-cause mortality in PREDIMED
- ↪ PREDIMED: Mediterranean diet with olive oil or nuts cut major CV events by 30% and 28%
- ↪ PREDIMED: each extra 10 g/day of olive oil cut CVD death 7%; top intake cut it 48%
- ↪ PREDIMED showed olive oil lowers atrial fibrillation risk (video)
- ↪ Higher extra virgin olive oil share was linked to lower Lp(a) in PREDIMED-Plus
- facebook.com/share/r/1CE3XCrFCM
- ↪ PREDIMED: free nuts roughly halved stroke risk, and walnuts may improve artery function
- ↪ PREDIMED follow-up: urinary tartaric acid links mild-moderate wine to HR 0.5 for CVD
CORDIOPREV:
- ↪ CORDIOPREV: Mediterranean diet shrank carotid plaque and cut recurrent events about 25%
- ↪ CORDIOPREV: Mediterranean diet reduced atherosclerosis versus low-fat diet over 7 years
Indo-Mediterranean Diet Heart Study:
- The Lancet article (The Lancet)
Quoted:
“Our analysis incorporated four RCTs involving a total of 10,054 participants, with an average age of 57 years and a mean follow-up duration ranging from 2 to 7 years. In our pooled analysis, the composite endpoint of major adverse cardiovascular events (MACE) demonstrated a statistically significant reduction in incidence in participants on MedDiet versus control diet with an OR of 0.52 (95 % CI: 0.32 to 0.84, p = 0.008; I2 = 87 %). Additionally, our study revealed a notable decrease in the incidence of cardiovascular events, both myocardial infarction (MI) and stroke in the the MedDiet group, with an OR of 0.62 (95 % CI: 0.41 to 0.92, p = 0.02; I2 = 56 %) and 0.63 (95 % CI: 0.48 to 0.87, p = 0.002; I2 = 0 %), respectively. However, no statistically significant change in the rate of revascularization was observed, with an OR of 0.74 (95 % CI: 0.30 to 1.27, p = 0.06; I2 = 16 %). Concerning mortality rates, MedDiet significantly reduced the risk of cardiovascular death with an OR of 0.54 (95 % CI: 0.31 to 0.94, p = 0.03; I2 = 55 %), while no significant change was noted in all-cause mortality, with an OR of 0.77 (95 % CI: 0.51 to 1.15, p = 0.20; I2 = 58 %).”
“MedDiet serves as an effective intervention for both primary and secondary prevention of CVD, demonstrating a substantial and long-term impact in reducing the incidence of MACE, MI, stroke, and cardiovascular-related mortality while showing no observed effect on all-cause mortality.”
#mediterraneanHD #lyonHD #predimedHD #cordioprevHD #indomediterraneanHD #mediterraneanrctHD